<1저자/교신저자>
1. Lee B, Song HH, Kim YR, Kim JH, Cho ST, Lee JH, Kim UK, Park JS. Identification of an in-frame homozygous KIF1A variant causing a mild SPG30 phenotype in a Korean family. Gene. 2023 Jun 20;870:147403.
2. Cho HJ, Shin JH, Park YE, Sohn E, Nam TS, Kang MG, Park JM, Park D, Park JS. Characteristics of spinal and bulbar muscular atrophy in South Korea: a cross-sectional study of 157 patients. Brain. 2023;146:1083-1092.
3. Park JM, Park D, Kim HJ, Park JS. Long-term outcomes of
edaravone in amyotrophic lateral sclerosis in South Korea: 72-week
observational study. BMC Neurol. 2022;22:260
4. Chang MC, Kwak SG, Park JM,
Park D, Park JS. Clinical and
electrophysiological characteristics of respiratory onset amyotrophic lateral
sclerosis: a single-centre study. Acta Neurol Belg. 2023;123:391-397.
5. Kang M, Kim S, Park JS, Seok HY. Myelin
oligodendrocyte glycoprotein antibody-associated optic neuritis following third
dose of BNT162b2 COVID-19 vaccine in a patient with systemic lupus
erythematosus. Neurol Sci. 2023;e-pub ahead of print
6. Park JS, Eah KY, Park JM.
Epidemiological profile of myasthenia gravis in South Korea using the national
health insurance database. Acta Neurol Scand. 2022 May;145(5):633-640
7. Kim S, Park JS, Lee JH, Shin HY, Yang HJ, Shin JH. Clinical,
electrophysiological, and genetic characteristics of cerebrotendinous
xanthomatosis in South Korea. Neurocase. 2022 Dec;28(6):477-482.
8. Kim N, Kim JH, Park JS. Guillain-Barre syndrome
associated with BNT162b2 COVID vaccination: a first case report from South
Korea. Neurol Sci. 2022 Mar;43(3):1491-1493
9. Kang MG, Gwak DW, Cho HJ, Min
YS, Park JS. Effect of
leuprorelin in bulbar function of spinal and bulbar muscular atrophy patients:
observational study for 1 year. J Neurol. 2021;268:3344-3351.
10. Park JS, Park D, Park JM, Cancer
frequency among the patients with myotonic dystrophy in the South Korean
population using the national health insurance database. J Neurol Sci
2021;15:420:117212.
11. Kim CS, Park JM, Park D, Kim
DH, Park JS. Opioid use may
be associated with postoperative complications in myotonic dystrophy type 1
with high-grade muscular impairment. Sci Rep. 2021 Jan 11;11(1):8
12. Oh SI, Oh J, Park D, Son K, Park JS. Reliability and
validity of the Korean version of the Spinal and bulbar muscular atrophy
functional rating scale. J Clin Neurol. 2020;16:586-591.
13. Ahn JW, Jeong JY, Hwang SK,
Shin HY, Park JS. A case of
diffuse large B cell lymphoma initially presenting as CLIPPERS: possible role
of the Epstein-Barr virus. Neurol Sci 2020; Epub ahead of print
14. Kim JY, Hwang SK, Kwon S, Park JS. Polymyoclonus
aggravated by neck flexion as the isolated presenting symptom of Hirayama
disease: case report. BMC Neurol 2020;20:325.
15. Park JM, Min YS, Park D, Park JS. Effect of Nusinersen in
a late onset spinal muscular atrophy patient for 14?months: A case report. Medicine (Baltimore). 2021 Jan
8;100(1):e24236.
16. Kim C, Park JS. Clinical characteristics of hereditary neuropathy
with liability to pressure palsy presenting with monoparesis in the emergency
department. Yeungnam Univ J Med. 2020;37:341-344.
17. Park SY, Park JM, Lee B, Kim
UK, Park JS. A novel REEP1
splicing mutation with broad clinical variability in a family with hereditary
spastic paraplegia. Gene 2020;765:145129.
18. Hwang J, Lim YH, Eun MY, Jeon
JY, Ko PW, Kim SH, Kang K, Lee HW, Park
JS. Lower glucose level associated with increased risk for post-dural
puncture headache. Headache 2020;60:1901-1909.
19. Ko PW, Min YS, Park JS. Likely pathogenic FIG4
related amyotrophic lateral sclerosis patient who correlated with clinical,
imaging and neurophychological studies. Ann Clin Neurophysiol. 2020;22:33-36.
20. Kim S, Lim YH, Kang K, Park D,
Lee HW, Park JS. Functional
Ambulation Profile (FAP) score as a potential biomarker of gait analysis in
Myotonic dystrophy type 1. Front Neurol 2020;11:392.
21. Park JM, Lee B, kim JH, Park
SY, Yu J, Kim UK, Park JS. An
autosomal dominant ERLIN2 mutation leads to a pure HSP phenotype distinct from
the autosomal recessive ERLIN2 mutations (SPG18). Sci Rep 2020;10:3295.
22. Park JM, Kim SY, Park D, Park JS. Effect of edaravone
therapy in Korean amyotrophic lateral sclerosis (ALS) patients. Neurol Sci
2020;41:119-123.
23. Woo JM, Lee HW, Park JS. Differences in the
pattern of cognitive impairments between juvenile and adult onset myotonic
dystrophy type 1. J Clin Neurosci 2019;68:92-96.
24. Park JM, Nishio H, Shin JH, Park JS. A spinal muscular
atrophy family with intrafamilial phenotype differences despite the same
copy-number variation in SMN2. J Clin Neurol 2019;15:177-180.
25. Park JS, Do YW, Park JM, Seok HY, Park
D. Under-recognized primary spontaneous pneumothorax in ALS: a multicenter
retrospective study. Neurol Sci 2019;40:2509-2514.
26. Lee B, Choi DG, Chun BY, Oh EH,
Lee YJ, Kim UK, Park JS. A
family with a mild form of congenital nystagmus and optic coloboma caused by a
novel APX6 mutation. Gene 2019;15:177-180.
27. Heo SJ, Jun JS, Park D, Lee HW,
Kim JS, Park JS.
Characteristics of obstructive apnea in Myasthenia gravis patients: a single
center study. Neurol Sci. 2019;40:719-724
28. Park JS, Ko JY, Park D. the
reversible effect of neck flexion on the somatosensory evoked potentials in
patients with Hirayama disease: a preliminary study. Neurol Sci 2019;40:181-186
29. Park JS, Song H, Jang KE, Cha H, Lee
SH, Hwang SK, Park D, Lee HJ, Kim JY, Chang Y. Diffusion tensor imaging and
voxel-based morphometry reveal corticospinal tract involvement in the motor
dysfunction of adult-onset myotonic dystrophy type 1. Sci Rep 2018;8:15592.
30. Park JM, Shin JH, Park JS. GNE myopathy with
prominent axial muscle involvement. J Clin Neurol 2018;14:580-582.
31. Park JS, Kim N, Park D. Diastolic
heart dysfunction is correlated with CTG repeat length in myotonic dystrophy
type 1. Neurol Sci 2018;39:1935-1943
32. Park JS, Park D. Spastic paraparesis
caused by x-linked adrenoleukodystrophy mimicking vacuolar myelopathy in a HIV
patient: A case report. Medicine 2018;97:e10756
33. Park D, Kim SH, Park JS. A novel CACNA1A
mutation associated with Episodic ataxia 2 presenting with periodic paralysis.
Acta Neurol belg 2018;118:137-139
34. Lee DH, Park D, Kim JK, Park JS. Usefulness of a phrenic
nerve conduction study is early diagnosis of isolated respiratory onset
amyotrophic lateral sclerosis: a case report. Journal of the Korean Society of
Emergency Medicine 2018;29:231-235
35. Park JS, Park D. Five year serial
follow-up of muscle MRI in adult onset myotonic dystrophy type 1: A case
report. Medicine 2018;97:e9379.
36. Park JS, Seo J, Song HJ, Lee SH,
Jang KE, Lee HJ et al. Altered power spectral density in the resting-state
sensorimotor network in patients with myotonic dystrophy type 1. Sci Rep
2018;8:987.
37. Park D, Lee SH, Park JS. Lower limb muscle
magnetic resonance imaging in Myotonic dystrophy type 1 correlates with the
six-minute walk test and CTG repeats. Neuromuscul Disord 2018;1:29-37.
38. Park JS, Park D. Reply to
“Prolongation of terminal latency of the phrenic nerve in amyotrophic lateral
sclerosis ? Is it clinically useful, and what are the mechanisms?”. Clin
Neurophysiol 2017;128:2095.
39. Park JS, Park D. The terminal
latency of the phrenic nerve correlates with respiratory symptoms in
amyotrophic lateral sclerosis. Clin Neurophysiol 2017;128:1625-1628.
40. Park JS, Park JY. Dermatitis sine
dermatitis, a rare phenotype of idiopathic inflammatory myopathy. Yeungnam Univ
J Med 2017;34:113-115.
41. Park JS, Park D, Ko PW, Kang K, Lee
HW. Serum methylmalonic acid correlates with neuropathic pain in idiopathic
Parkinson`s disease. Neurol Sci 2017
42. Park D, Park JS. Quantitative assessment of trunk muscles
involvement in patients with Myotonic dystrophy type 1 using a whole body
muscle magnetic resonance imaging. Eur Neurol 2017;77:238-245.
43. Park D, Park JS. Terminal latency abnormality in amyotrophic lateral
sclerosis without split hand syndrome. Neurol Sci 2017;38:775-781.
44. Park JM. Lee HC, Park JS. Remission after rituximab
therapy in refractory Myasthenia gravis. J Korean Neurol Assoc 2017;35:26-29.
45. Park JS, Shin JH. Myelopathy caused
by surfing. J Korean Neurol Assoc 2016;34:391-393.
46. Park JS. Clinical evaluation of
channelopathies. Korean J Neuromuscul Dis. 2016;8:34-38.
47. Jeon JS, Park JS. An early treated neuralgic amyotrophy with
bilateral phrenic nerve involvement with favorable outcome. Neurol India
2016;64:566-569.
48. Park JM, Kim NK, Park JS. An adverse event of
pulmonary thromboembolism after intravenous immunoglobulin therapy in
Guillain-Barre syndrome. Korean J Clin Neurophysiol 2016;18:14-17.
49. Park JS, Hwang SJ, Shin JH.
Phenotypic difference of CLCN1 gene variant (A313T) in a Korean family with
Myotonia congenita. J Korean Neurol Assoc 2016;34:220-223
50. Park JS, Kim DS, Shin JH. A family
with dynamin 2-related centronuclear myopathy without ocular involvement. J
Genet Med 2016;13:51-54.
51. Choi WC, Heo SJ, Park JS. A case of generalized
Myasthenia gravis with spasmodic dysphonia. J Korean Neurol Assoc
2016;34:138-141.
52. Park JS, Lee SH. The abnormalities
in neuro-imaging and somatosensory evoked potentials in Hirayama disease.
Korean J Clin Neurophysiol 2015;17:38-40.
53. Park JS, Lee JN, Shin JH. Isolated
unilateral leg weakness as the presenting symptom of primary aldosteronism: a
case report. Acta Neurol Belg. 2015;115:501-503.
54. Park JS, Kim HG, Shin JH, Choi YC,
Kim DS. Effect of enzyme replacement therapy in late onset Pompe disease: open
pilot study of 48 weeks follow-up. Neurol Sci. 2015;36:599-605.
55. Park JS, Park SP, Seo JG. Hirayama
disease with juvenile myoclonic epilepsy: A case report. Ann Indian Acad Neurol
2014;17:358-60.
56. Park JS, Choi DH, Lee HW. A case of
Ramsay hunt syndrome with multicranial nerve palsy. Korean J Clin Neurophysiol.
2013;15:71-73.
57. Park JS, Hwang SJ, Shin JH, Kim DS.
A recurrent longitudinally extensive transverse myelitis with Aquaporin4(AQP4)
antibody after herpes zoster. J Neurol Sci
2013;334:69-71.
58. Park JS, Huh SY, Jung NY, Shin JH,
Byun SY, Kim DS. Congenital myotonic dystrophy pathologically mimicking
X-linked myotubular myopathy. Korean J Clin Neurophysiol 2012;14(2):80-2.
59. Park JS, Kim JG, Park PS, Lee HW.
Asymmetric chorea as presenting symptom in Graves` disease. Neurol Sci.
2012;33:343-345
60. Park JS, Lee HW, Park SP. Reversible
parkinsonism associated with acute arsenic intoxication. J Korean Neurol Assoc.
2011;29(3):272-273
<공저자>
1. Nam JY, Chun S, Lee TY, Seo Y,
Kim K, Park J, Sung W, Oh KW, Lee S, Park JS, Oh J, Chung KC, An H, Chu HS, Son
B, Kim SH. Long-term survival benefits of intrathecal autologous bone
marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment
in ALS: Propensity-score-matched control, surveillance study. Front Aging
Neurosci. 2023;15:1148444
2. Kwon YN, Woodhall M, Sung JJ,
Kim KK, Lim YM, Kim H, Kim JE, Baek SH, Kim BJ, Park JS, Seok HY, Kim DS, Kwon
O, Park KH, Sohn E, Bae JS, Yoon BN, Kim NH, Ahn SW, Choi K, Oh J, Park HJ,
Shin KJ, Lee S, Park J, Kim SH, Seok JI, Bae DW, An JY, Joo IS, Choi SJ, Nam
TS, Kim S, Park KJ, Kwon KH, Waters P, Hong YH. Clinical pitfalls and
serological diagnostics of MuSK myasthenia gravis. J Neurol. 2023
Mar;270(3):1478-1486
3. Hwang JM, Kim JH, Park JS,
Chang MC, Park D. Neurological diseases as mortality predictive factors for
patients with COVID-19: a retrospective cohort study. Neurol Sci
2020;41:2317-2324.
4. Chang MC, Kwak SG, Park JS,
Park D. The effectiveness of nonsteroidal anti-inflammatory drugs and
acetaminophen in reduce the risk of amyotrophic lateral sclerosis? A meta
analysis. Sci Rep 2020;10:14759.
5. Lee AJ, Nam SH, Park JM, Kanwal
S, Choi YJ, Lee HJ, lee KS, Lee JE, Park JS, Choi BO, Chung KW. Compound
heterozygous mutations of SH3TC2 in Charcot-Marie-Tooth disease type 4C
patirnts. J Human Genet 2019;64:961-965.
6. Kim CH, Hwang JM, Park JS, Han
S, Park D. Predictability of severity of disc degeneration and disc protrusion
using horizontal displacement of cervical dynamic radiographs. A retrospective
comparison study with MRI. Medicine 2018;97:e11098
7. Kim JY, Chun SY, Park JS, Chung
JW, Ha YS, Lee JN et al. Laminin and platelet-derived growth factor-BB promote
neural differentiation of human urine-derived stem cells. Tissue Eng Regen Med
2018;doi.org/10.1007/s13770-017-0102-x.
8. Lee JH, Park JS, Park D.
Successful IVIG treatment without discontinuation of TNF-a blocker in
Guillain-Barre syndrome induced by adalimumab in patient with Crohn`s disease.
Neurol Sci 2017;doi:10.1007/s10072-017-3179-z.
9. Kim SY, Shin JH, Park JS, Kang SY, Nam TS, Kim JK et al. NUDT15 pR139C variant is common and strongly associated with azathioprine-indiced early leukopenia and severe alopecia in Korean patients with various neurological disease. J Neurol Sci 2017;378:64-68.
10. Hwang J, Go PW, Park JS, Song HS. Contralateral sensory loss of temperature and pain below the fourth thoracic dermatome caused by a cavernous angioma in dorsolateral midbrain. Korean J Stroke. 2010;12:121-122